ITK inhibitor 6
ITK inhibitor 6 (compound 43) is a potent and selective ITK inhibitor with IC50s of 4 nM, 133 nM, 320 nM, 2360 nM, 155 nM for ITK, BTK, JAK3, EGFR, LCK, respectively. ITK inhibitor 6 inhibits phosphorylation of PLCγ1 and ERK1/2. ITK inhibitor 6 shows antiproliferative activities.
For research use only. We do not sell to patients.
- CAS No.: 2404604-06-2
- Formula: C28H24F2N4O2
- Molecular Weight:486.51
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
IC50: 4 nM (ITK); 133 nM (BTK), 320 nM (JAK3), 2360 nM (EGFR), 155 nM (LCK)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CCRF-CEM | GI50 |
3.4 μM
Compound: 43
|
Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
|
[PMID: 31830635] |
| H9 | GI50 |
5.4 μM
Compound: 43
|
Antiproliferative activity against human H9 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
Antiproliferative activity against human H9 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
|
[PMID: 31830635] |
| HEK-293T | GI50 |
19 μM
Compound: 43
|
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
|
[PMID: 31830635] |
| Jurkat | EC50 |
119 nM
Compound: 43
|
Inhibition of ITK in anti-CD3/CD28 beads-stimulated human Jurkat cells assessed as reduction in Plcgamma1 phosphorylation incubated for 2 hrs followed by stimulation with anti-CD3/CD28 beads by Western blot analysis
Inhibition of ITK in anti-CD3/CD28 beads-stimulated human Jurkat cells assessed as reduction in Plcgamma1 phosphorylation incubated for 2 hrs followed by stimulation with anti-CD3/CD28 beads by Western blot analysis
|
[PMID: 31830635] |
| Jurkat | GI50 |
5.1 μM
Compound: 43
|
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
|
[PMID: 31830635] |
| MOLT-4 | GI50 |
3.7 μM
Compound: 43
|
Antiproliferative activity against human MOLT4 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
Antiproliferative activity against human MOLT4 cells assessed as reduction in cell viability incubated for 72 hrs by cell titer glo luminescence based assay
|
[PMID: 31830635] |
In Vitro
ITK inhibitor 6 (compound 43) shows antiproliferative activities with GI50s of 5.1, 3.7, 3.4, 5.4, 19 µM for Jurkat, Molt-4, CCRF-CEM, H9, HEK 293 T cells, respectively[1].
ITK inhibitor 6 docks into the ATP-binding site of ITK and BTK[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 2404604-06-2
-
Molecular Weight 486.51
-
Formula C28H24F2N4O2
-
SMILES
C=CC(NCCOC1=C2C=C(NC2=CC(CC3=CC=CC=C3)=C1)C4=NNC5=C4C=CC(C(F)F)=C5)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)